M.D. Anderson Cancer Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, M.D. Anderson Cancer Center sits in the top decile of US sponsors by registered trial count (#3 of 15,751 sponsors by registered trial count).

2,692 total trials 549 currently recruiting 1201 completed early-phase tilt top decile by trial count

M.D. Anderson Cancer Center: 2,692 sponsored US clinical trials, 549 recruiting.

M.D. Anderson Cancer Center sponsors 2,692 registered US clinical trials on ClinicalTrials.gov, 549 of them currently recruiting, and 1,201 completed. 124 of these trials are in Phase 3-4 (later-stage) and 1,719 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hematopoietic and Lymphoid Cell Neoplasm, with 44 trials.

Top-decile sponsor footprint

M.D. Anderson Cancer Center ranks in the top decile of sponsors by registered trial count (#3 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,692 total, page 54 of 54

COMPLETED Phase 2

Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer

NCT00004136
COMPLETED Phase 2

Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia

NCT00003239
COMPLETED Phase 1

Doxorubicin Plus External-Beam Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

NCT00004109
COMPLETED Phase 2

2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES)

NCT00483067
COMPLETED Phase 2

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

NCT00003245
COMPLETED Phase 2

Mini-Allogeneic Peripheral Blood Progenitor Cell Transplantation For Recurrent or Metastatic Breast Cancer

NCT00429572
COMPLETED Phase 3

Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial

NCT00460395
COMPLETED NA

Allogeneic Blood Stem Cell Transplantation

NCT00423709
COMPLETED Phase 2

Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer

NCT00003084
TERMINATED Phase 2

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

NCT00038142
COMPLETED Phase 2

Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

NCT00005991
COMPLETED Phase 1

Interleukin-12 in Treating Patients With Cancer in the Abdomen

NCT00003046
COMPLETED Phase 1

Radiation Therapy Plus Doxorubicin in Treating Patients With Resectable Primary or Recurrent Retroperitoneal Soft Tissue Sarcoma

NCT00004123
COMPLETED Phase 2

Amifostine in Treating Patients With Myelodysplastic Syndrome

NCT00003048
COMPLETED Phase 2

Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas

NCT00002965
COMPLETED Phase 2

Recombinant Interferon Alpha and Etoposide in Relapsed Osteosarcoma

NCT00504140
TERMINATED NA

Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States

NCT00038779
COMPLETED Phase 3

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

NCT00002855
COMPLETED Phase 2

Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease

NCT01404936
COMPLETED Phase 2

Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer

NCT00003099
COMPLETED Phase 1

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia

NCT00002838
COMPLETED Phase 3

Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma

NCT00002882
COMPLETED Phase 3

Combination Chemotherapy in Treating Patients With Lymphoma

NCT00002835
COMPLETED Phase 3

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

NCT00002836
COMPLETED Phase 1

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

NCT00038441
COMPLETED Phase 1

High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer

NCT00002837
COMPLETED Phase 2

Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach

NCT00002682
COMPLETED Phase 1

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

NCT00002831
COMPLETED Phase 1

Decitabine and Peripheral Stem Cell Transplantation in Treating Patients Who Have Relapsed Following Bone Marrow Transplantation for Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00002832
COMPLETED Phase 1

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

NCT00004246
COMPLETED Phase 2

Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia

NCT00002833
COMPLETED Phase 2

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

NCT00038025
COMPLETED Phase 3

Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma

NCT00002565
COMPLETED Phase 2

Bone Marrow Transplantation in Treating Patients With Lymphoma

NCT00002829
COMPLETED Phase 2

Combined Modality Treatment for Resectable Non-Small Cell Superior Sulcus Tumors

NCT00984997
COMPLETED Phase 2

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

NCT00002524
COMPLETED Phase 3

Fenretinide in Treating Patients With Cervical Neoplasia

NCT00003075
COMPLETED NA

IUdR/BUdR Cell Cycle Labelling

NCT00042250
COMPLETED Phase 2

Bone Marrow Transplantation in Treating Patients With Chronic Lymphocytic Leukemia

NCT00002844
COMPLETED Phase 2

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

NCT00038376
COMPLETED Phase 2

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors

NCT00002463
COMPLETED Phase 3

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

NCT00037843
← Previous Page 54 of 54

Phase Distribution

PhaseTrial count
Phase 1 748
Phase 2 971
Phase 3 96
Phase 4 28

Therapeutic Areas

Hematopoietic and Lymphoid Cell Neoplasm 44
Malignant Solid Neoplasm 42
Breast Cancer 41
Acute Myeloid Leukemia 38
Leukemia 37
Myelodysplastic Syndrome 33
Lymphoma 32
Cancer 31
Recurrent Acute Myeloid Leukemia 25
Lung Cancer 23

What is open in the M.D. Anderson Cancer Center pipeline

549 recruiting of 2,692 indexed (20% open); 1,201 completed (45%).

Phase mix: 124 late (III/IV) vs 1,719 early (I/II) (early-phase heavy).

Top condition: Hematopoietic and Lymphoid Cell Neoplasm (44 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Related

Compare saved trials side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.